- Home
- SGRP vs GDTC Comparison
SGRP vs GDTC Comparison
Compare SGRP & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- GDTC
- Stock Information
- Founded
- SGRP 1967
- GDTC 2018
- Country
- SGRP United States
- GDTC Singapore
- Employees
- SGRP N/A
- GDTC N/A
- Industry
- SGRP Business Services
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- SGRP Consumer Discretionary
- GDTC Health Care
- Exchange
- SGRP Nasdaq
- GDTC Nasdaq
- Market Cap
- SGRP 27.8M
- GDTC 28.0M
- IPO Year
- SGRP 1996
- GDTC 2023
- Fundamental
- Price
- SGRP $1.04
- GDTC $2.35
- Analyst Decision
- SGRP
- GDTC Buy
- Analyst Count
- SGRP 0
- GDTC 1
- Target Price
- SGRP N/A
- GDTC $5.00
- AVG Volume (30 Days)
- SGRP 43.2K
- GDTC 9.6K
- Earning Date
- SGRP 05-27-2025
- GDTC 01-01-0001
- Dividend Yield
- SGRP N/A
- GDTC N/A
- EPS Growth
- SGRP N/A
- GDTC N/A
- EPS
- SGRP 0.50
- GDTC N/A
- Revenue
- SGRP $228,869,000.00
- GDTC $368,838.00
- Revenue This Year
- SGRP N/A
- GDTC $5.37
- Revenue Next Year
- SGRP N/A
- GDTC N/A
- P/E Ratio
- SGRP $2.14
- GDTC N/A
- Revenue Growth
- SGRP N/A
- GDTC N/A
- 52 Week Low
- SGRP $1.00
- GDTC $1.20
- 52 Week High
- SGRP $3.12
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- SGRP 34.96
- GDTC 49.94
- Support Level
- SGRP $1.00
- GDTC $2.26
- Resistance Level
- SGRP $1.08
- GDTC $2.60
- Average True Range (ATR)
- SGRP 0.05
- GDTC 0.13
- MACD
- SGRP 0.01
- GDTC 0.00
- Stochastic Oscillator
- SGRP 26.67
- GDTC 40.38
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.